Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (35)

2024

  1. Frailty and sarcopenia in patients with acute-on-chronic liver failure: Assessment and risk in the liver transplant setting

    Annals of Hepatology, Vol. 29, Núm. 5

  2. Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

    Scientific Reports, Vol. 14, Núm. 1

  3. Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 30, Núm. 2, pp. 170-181

  4. Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

    Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912

  5. Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation

    Frontiers in Immunology, Vol. 15

  6. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis

    Liver International, Vol. 44, Núm. 2, pp. 279-285

2023

  1. Proceedings of the 27th Annual Congress of the International Liver Transplantation Society

    Transplantation

2022

  1. High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation

    Clinical and Translational Science, Vol. 15, Núm. 6, pp. 1544-1555

  2. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients

    American Journal of Transplantation

  3. Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study

    Diagnostics, Vol. 12, Núm. 7

  4. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study

    Liver Transplantation, Vol. 28, Núm. 7, pp. 1257-1261

  5. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy

    Annals of Hepatology, Vol. 27, Núm. 3

  6. Transplantation, HIV Serostatus, and Registry Data: Room for Improvement

    American Journal of Transplantation

  7. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations

    Clinical Transplantation, Vol. 36, Núm. 10

2021

  1. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement

    Journal of Hepatology, Vol. 75, Núm. 2, pp. 275-283

  2. Covid-19 clinical profile in latin american migrants living in spain: Does the geographical origin matter?

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  3. Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort

    Transplant International, Vol. 34, Núm. 10, pp. 1908-1913

  4. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus

    American Journal of Transplantation, Vol. 21, Núm. 9, pp. 3148-3156

  5. Recommendations and guidance on nutritional supplementation in the liver transplant setting

    Transplantation, Vol. 105, Núm. 12, pp. 2528-2537

2020

  1. Does retraction after misconduct have an impact on citations? A pre-post study

    BMJ Global Health, Vol. 5, Núm. 11